Keyword: Zydus

India's Zydus Cadila says the FDA has issued a warning letter for its injectables facility in Moraiya, its second in four years.

Price remains a stumbling block in a potential $1 billion deal for for Indian biopharma player Bharat Serums and Vaccines.

Kroger and other grocery chains are suing Mylan, Teva, Endo and many other companies for an "overarching conspiracy" to artificially inflate prices.

Sanofi, aiming to sharpen its focus by offloading its EU generics, is reportedly drawing shoppers from across the globe. The deal could be worth $2B.

Zydus Cadila, an Indian injectables maker, said it reached a deal with Russia’s Pharm Aid to manufacture its varicella vaccine for the Russian Federation.

Zydus Cadila is launching a generic of Shire's lucrative ulcerative colitis drug Lialda, several years ahead of what Shire investors had expected.

The FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. This month, they've cited six drugmakers, more than half the enforcement actions all year.

With India in the throes of an outbreak of Chikungunya, local drugmaker Zydus Cadila has stepped up to develop a vaccine against the crippling viral disease--with help from Japan's Takeda.